Literature DB >> 1517893

Degranulation of cystic fibrosis nasal polyp mast cells.

W R Henderson1, E Y Chi.   

Abstract

The ultrastructure of nasal polyps from cystic fibrosis (CF) patients was compared with non-CF nasal polyps in this study. Morphometric analysis showed that CF nasal polyps contained greater numbers of mast cells, endothelial cells, lymphocytes, and plasma cells compared with the non-CF specimens. Morphologic evidence of degranulation was seen in approximately 30 per cent of the CF mast cells but was not observed in the non-CF mast cells. Increased numbers of small granules, vacuolated granules, and lipid bodies were noted in the CF compared with the non-CF nasal polyp mast cells. Also observed was a decrease in collagen in the extracellular space of the CF nasal polyps compared with the non-CF specimens. Although eosinophils were observed in the non-CF nasal polyp tissue, these leukocytes were absent in the CF nasal polyps. These data indicate that striking morphologic differences exist between CF and non-CF nasal polyps with mast cell degranulation, a salient feature of CF specimens.

Entities:  

Mesh:

Year:  1992        PMID: 1517893     DOI: 10.1002/path.1711660412

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  9 in total

1.  Etiology of nasal polyps in cystic fibrosis: not a unimodal disease.

Authors:  John W Steinke; Spencer C Payne; Philip G Chen; Julie Negri; Edward B Stelow; Larry Borish
Journal:  Ann Otol Rhinol Laryngol       Date:  2012-09       Impact factor: 1.547

Review 2.  Pathogenesis and management of nasal polyposis in cystic fibrosis.

Authors:  Jochen G Mainz; Assen Koitschev
Journal:  Curr Allergy Asthma Rep       Date:  2012-04       Impact factor: 4.806

Review 3.  Key role of mast cells and their major secretory products in inflammatory bowel disease.

Authors:  Shao-Heng He
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

4.  Selective early production of CCL20, or macrophage inflammatory protein 3alpha, by human mast cells in response to Pseudomonas aeruginosa.

Authors:  Tong-Jun Lin; Lauren H Maher; Kaede Gomi; Jeffrey D McCurdy; Rafael Garduno; Jean S Marshall
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

5.  Cystic fibrosis: ultrastructural changes of nasal mucosa.

Authors:  Stephan Knipping; Hans Juergen Holzhausen; Andreas Riederer; Marc Bloching
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-07-21       Impact factor: 2.503

6.  Influence of Pseudomonas aeruginosa quorum sensing signal molecule N-(3-oxododecanoyl) homoserine lactone on mast cells.

Authors:  Hongtao Li; Lili Wang; Lu Ye; Yan Mao; Xuhua Xie; Chao Xia; Jia Chen; Zimin Lu; Jianxin Song
Journal:  Med Microbiol Immunol       Date:  2009-04-01       Impact factor: 3.402

7.  Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis.

Authors:  Cecilia K Andersson; Annika Andersson-Sjöland; Michiko Mori; Oskar Hallgren; Annie Pardo; Leif Eriksson; Leif Bjermer; Claes-Göran Löfdahl; Moises Selman; Gunilla Westergren-Thorsson; Jonas S Erjefält
Journal:  Respir Res       Date:  2011-10-20

8.  The importance of leukotrienes in airway inflammation in a mouse model of asthma.

Authors:  W R Henderson; D B Lewis; R K Albert; Y Zhang; W J Lamm; G K Chiang; F Jones; P Eriksen; Y T Tien; M Jonas; E Y Chi
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

Review 9.  Immunomodulation in Cystic Fibrosis: Why and How?

Authors:  Vincent D Giacalone; Brian S Dobosh; Amit Gaggar; Rabindra Tirouvanziam; Camilla Margaroli
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.